After more than 20 years on the Turkish market Chr. Hansen acquires the remaining 50% of Peyma Chr-Hansen A.S.
Chr. Hansen is investing in the future by acquiring the remaining 50% of the shares of its Turkish subsidiary, Peyma Chr-Hansen A.S. Turkey is a strategically important market seeing steady growth in both cultures, enzymes and natural colors, and Chr. Hansen wishes to strengthen and expand its activities in the region.
“We have been present with the Peyma Chr-Hansen Joint Venture in Turkey since 1989. With this acquisition we can fully integrate operations into the rest of the Chr. Hansen organization, sustaining the whole Group’s success in the future,” explains Jacob Vishof Paulsen, Group Vice President, Europe, Middle East and Africa, Chr. Hansen.
The take-over takes place in full consensus with the General Manager and shareholder, Mr Toni Ciprut.
“We wish to thank Mr Ciprut for his efforts and his success throughout the many years. He has been instrumental in making Chr. Hansen a major player on the Turkish food ingredients market, and I am pleased to announce that he will continue to support the management team as a consultant over the coming two years,” says Jacob Vishof Paulsen.
On his part Toni Ciprut is pleased to see his life’s work continue under new strong ownership: “I have always enjoyed cooperating with Chr. Hansen and I am happy to envisage a good future for the business. I look forward to assuming my new advisory role over next two years, which will ensure a continued strong bond to the company as well as more time for me to spend with family and friends,” he notes.
New country manager
The role of new Country Manager of Chr. Hansen Turkey will be assumed by Mr Carsten Rou, who has been with Chr. Hansen for 25 years, most recently as Head of culture and enzyme sales in North America.
Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2013/14 financial year was EUR 756 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.